Ashwin Lewis
Miltown, the brand name for the generic drug meprobamate, was the first minor tranquilizer to be marketed to the public. Launched in 1955 by Wallace Laboratories, a subsidiary of Carter Products, it quickly became the first blockbuster psychotropic drug in the United States, becoming a cultural phenomenon. Miltown was initially marketed as a treatment for anxiety, but it also became popular as a sleeping pill due to its calming and sedative effects.
| Characteristics | Values |
|---|---|
| Generic Name | Meprobamate |
| Brand Names | Miltown, Trancot, Bamate, Equanil, Meprospan, Neuramate, Tranmep, Mb-Tab |
| Drug Class | Miscellaneous anxiolytics, sedatives and hypnotics |
| Use | To relieve nervousness or tension, treat anxiety |
| Side Effects | Drowsiness, dizziness, trouble with balance or coordination |
| Addiction | Risk of addiction and withdrawal symptoms |
| Availability | Discontinued in the U.S., generic alternatives may be available |
| Storage | Room temperature, between 68 F and 77 F (20 C and 25 C) |
Explore related products
![GenCare Maximum Strength Nighttime Sleep Aid Supplement for Adults Deep Sleep Pills with Diphenhydramine HCl 50mg to Fall Asleep Faster- Strong Non-Habit Forming PM Sleeping Relief [96 Softgels]](https://m.media-amazon.com/images/I/71WC6IGWvcL._AC_UY218_.jpg)
What You'll Learn
Miltown was the first blockbuster psychotropic drug in the US
Miltown, the brand name for the generic drug meprobamate, was the first blockbuster psychotropic drug in the United States. It was launched in 1955 by Wallace Laboratories, a subsidiary of Carter Products. The drug is a carbamate derivative used as an anxiolytic and was the best-selling minor tranquilizer for a time. It was discovered by Frank Berger, who noticed that a compound called mephenesin calmed laboratory rodents without sedating them. He referred to this "tranquilizing" effect in a historic article published in 1946.
Miltown was initially slow to take off, with only $7,500 worth of sales in the first month after its launch. However, by the end of 1955, sales had reached $2 million. The drug became popular in Hollywood, with celebrities passing the pills around at parties. It soon became a cultural phenomenon, appearing in New Yorker cartoons and on greeting cards. Comedians made jokes about the drug, and it was even featured in cocktails called "miltinis." By late 1956, one in 20 Americans had tried Miltown.
The drug was heavily advertised to the general public, with celebrity endorsements from stars like Milton Berle, who promoted the drug on his television show, calling himself "Uncle Miltown." Miltown was also marketed under more than 100 trade names, including Amepromat and Equanil. It was prescribed to treat anxiety and produce a calming effect by slowing down different areas of the brain and nerve activities. However, it also carried the risk of addiction and withdrawal symptoms.
Miltown's popularity set the stage for its own demise, as other pharmaceutical companies rushed to develop the next best thing. It has since been largely replaced by benzodiazepines due to their wider therapeutic index and lower risk of toxicity and serious side effects. While Miltown is no longer on the market, it laid the foundation for how we treat anxiety today and normalized the idea of taking medication for everyday ailments.
Safe Sleeping Pills to Take with Biaxin
You may want to see also
Explore related products
The drug was named after Milltown, New Jersey
Miltown, the brand name for the generic drug meprobamate, was named after Milltown, New Jersey. Marketed by Wallace Laboratories, a subsidiary of Carter Products, the drug was launched in 1955 and quickly became the first blockbuster psychotropic drug in American history. It was one of the first drugs to be widely advertised to the general public, with celebrity endorsements from stars like Milton Berle, who called himself "Uncle Miltown" and joked about his love for the drug.
Miltown was initially intended as a minor tranquilizer to treat anxiety and produce a calming effect. It worked by slowing down different areas of the brain and nerve activities. The drug took off without a major marketing push, largely due to its popularity in Hollywood. It soon became a cultural phenomenon, with one in 20 Americans having tried it by late 1956. The pill was passed around at parties, and cocktails called "miltinis" combined alcohol with the pills.
The healthcare company Carter-Wallace, responsible for bringing Miltown to market, was initially reluctant to do so. They needed to be persuaded that there was enough worry in the world to warrant a pill to treat it. However, once Miltown took off, it became incredibly popular, with sales hitting $2 million by the end of its first year on the market.
Miltown's popularity laid the foundation for how we treat anxiety today. It normalized the idea that people without serious illnesses could take a pill to manage the everyday ups and downs of life. Despite its popularity, some doctors became disillusioned with Miltown, doubting its effectiveness as a tranquilizer and expressing concerns about its potential for addiction and withdrawal symptoms.
Nytol: A Natural Sleep Aid or a Sleeping Pill?
You may want to see also
Explore related products
Miltown was the first minor tranquilizer
Miltown, also known as Meprobamate, was the first minor tranquilizer to be launched in 1955. It was initially marketed by Wallace Laboratories, a subsidiary of Carter Products, and named after the borough of Milltown, New Jersey. Although its launch was underwhelming, with only $7,500 worth of sales in the first month, Miltown soon became a blockbuster drug. By the end of 1955, its sales had skyrocketed to $2 million.
Miltown was one of the first drugs to be widely advertised to the general public, with celebrity endorsements from stars like Milton Berle, who promoted the drug heavily on his television show, even calling himself "Uncle Miltown". The drug's popularity continued to soar, and by 1956, one in 20 Americans had tried it. It became a cultural phenomenon, appearing in New Yorker cartoons, greeting cards, and even cocktails called "miltinis".
Miltown was used to treat anxiety and nervousness by slowing down brain and nerve activities to produce a calming effect. It was particularly popular because, unlike barbiturates, it eased anxiety without causing sedation. However, it had its drawbacks, including side effects such as drowsiness, dizziness, and balance issues. Some doctors also expressed doubts about its effectiveness, believing it to be a mild sedative with no more tranquilizing effect than a sugar pill.
Despite these concerns, Miltown laid the foundation for how we treat anxiety today and normalized the idea of taking medication for everyday issues. It was eventually replaced by benzodiazepines due to their wider therapeutic index and lower risk of serious side effects, but its impact on the pharmaceutical industry and popular culture was significant.
Unlocking La Prairie Skin Caviar Sleep Mask Benefits
You may want to see also
Explore related products
It was heavily advertised to the general public
Miltown, the brand name for the generic drug meprobamate, was one of the first drugs to be widely advertised directly to the general public. Launched in 1955 by Carter-Wallace, a subsidiary of Carter Products, it rapidly became the first blockbuster psychotropic drug in American history.
Meprobamate was initially discovered by accident. Frank Berger, working in a laboratory of a British drug company, was searching for a preservative for penicillin when he noticed that a compound called mephenesin (or myanesin) calmed laboratory rodents without actually sedating them. He subsequently referred to this “tranquilizing” effect in an article published by the British Journal of Pharmacology in 1946.
Despite this, Carter-Wallace was initially reluctant to put the drug on the market, and its introduction was underwhelming, selling just $7,500 worth during the first month. However, this soon changed when Hollywood discovered Miltown, and the pill became a cultural phenomenon. By the end of 1955, sales had hit $2 million. The drug was heavily promoted by user Milton Berle on his television show, where he called himself 'Uncle Miltown'.
Miltown soon became ubiquitous in 1950s American life, with 1 in 20 Americans having used it by late 1956. It was even combined with alcohol in cocktails with Cold War-inspired names, such as "miltinis". The popularity of the drug meant that by 1960, Carter Products, Inc. and American Home Products Corporation (which marketed meprobamate as Equanil) were charged with having conspired to monopolize the market in mild tranquilizers. It was revealed that the sale of meprobamate earned $40,000,000 for the defendants.
Meprobamate was used to treat anxiety and worked by slowing down different areas of the brain and nerve activities to produce a calming effect. It has since been replaced by benzodiazepines due to their wider therapeutic index and lower incidence of serious side effects.
How TDCS Devices Improve Sleep Quality
You may want to see also
Explore related products
Miltown was discontinued in the US
Miltown, the brand name for the drug meprobamate, was discontinued in the US. Launched in 1955, it was the first blockbuster psychotropic drug in American history and became a cultural phenomenon.
Miltown was initially marketed as a minor tranquilizer to treat anxiety. It was one of the first drugs to be widely advertised to the general public, with celebrity endorsements from stars like Milton Berle, who joked about the drug on his talk show. By the end of 1956, one in 20 Americans had tried Miltown.
The drug was embraced by Hollywood and soon became ubiquitous in 1950s American life. However, its popularity began to wane as doctors became disillusioned with its effectiveness. Some doubted that it had any more of a tranquilizing effect than a placebo, while others believed it was a mild sedative that worked no better than older and cheaper drugs. There were also concerns about the addictive nature of Miltown, with physicians reporting that it could cause addiction and withdrawal symptoms in some patients.
The healthcare company responsible for bringing Miltown to market, Carter-Wallace, was initially reluctant to do so. The drug took off without a major marketing push, and its popularity exploded, leading to a rush by other pharmaceutical companies to discover the next big thing. This contributed to Miltown's demise, as competitors sought to capitalize on the market potential for anxiety and depression treatments.
Today, meprobamate is largely replaced by benzodiazepines due to their wider therapeutic index and lower risk of toxicity at therapeutic doses. While Miltown is discontinued in the US, generic alternatives may be available.
Sleeping Pills: When to Consider Taking Them
You may want to see also
Frequently asked questions
Miltown was the brand name for the drug meprobamate, a minor tranquilizer used to treat anxiety.
Meprobamate was used to treat anxiety and produce a calming effect. It was also used to relieve nervousness or tension and aid sleep.
Miltown worked by slowing down different areas of the brain and nerve activity.
Miltown was not solely a sleeping pill, but it was sometimes used to aid sleep. It was primarily used to treat anxiety and relieve nervousness or tension.
Miltown was initially brought to market by Carter-Wallace, a healthcare company, in May 1955. It was discovered by Frank Berger, who noticed that a compound calmed laboratory rodents without sedating them.
